metoclopramide has been researched along with MS (Multiple Sclerosis) in 2 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yusuf, K | 1 |
| Chen, S | 1 |
| Seeman, P | 1 |
| Liu, F | 1 |
2 other studies available for metoclopramide and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
One face behind the numbers.
Topics: Adult; Antiemetics; Clinical Trials as Topic; Diphenhydramine; Female; Glucocorticoids; Humans; Meth | 2009 |
Antipsychotic drug binding in the substantia nigra: an examination of high metoclopramide binding in the brains of normal, Alzheimer's disease, Huntington's disease, and Multiple Sclerosis patients, and its relation to tardive dyskinesia.
Topics: Alzheimer Disease; Animals; Antipsychotic Agents; Dopamine Antagonists; Dose-Response Relationship, | 2011 |